FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/03/032324 [Registered on: 26/03/2021] Trial Registered Prospectively
Last Modified On: 25/03/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Using two Anaesthesia drugs Bupivacaine and fentanyl as premixture versus sequential injection for leg operations 
Scientific Title of Study   COMPARING EFFICACY OF INTRATHECAL BUPIVACAINE AND FENTANYL AS A PREMIXTURE VERSUS SEQUENTIAL ADMINISTRATION IN LOWER LIMB SURGERIES": RANDOMIZED CONTROL TRIAL 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Reema Kaul 
Designation  Postgraduate 
Affiliation  Sahyadri Narayana multispeciality hospital 
Address  Sahyadri Narayana Multispeciality hospital, NT road Harikeri. Department of anaesthesia
NT road Harikeri , department of anaesthesia
Shimoga
KARNATAKA
577202
India 
Phone  7829726531  
Fax    
Email  kaulreema999@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Ajith Kumar Shetty 
Designation  HOD 
Affiliation  Sahyadri Narayana multispeciality hospital 
Address  Sahyadri Narayana Multispeciality hospital ,NT road Harikeri, department of anaesthesia
NT road Harikeri , department of anaesthesia
Shimoga
KARNATAKA
577202
India 
Phone  9448125388  
Fax    
Email  ajithshetty.shetty@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Reema Kaul 
Designation  Postgraduate 
Affiliation  Sahyadri Narayana multispeciality hospital 
Address  Sahyadri Narayana Multispeciality hospital, NT road Harikeri, department of anaesthesia
NT road Harikeri , department of anaesthesia
Shimoga
KARNATAKA
577202
India 
Phone  7829726531  
Fax    
Email  kaulreema999@gmail.com  
 
Source of Monetary or Material Support  
Narayana multispeciality hospital 
 
Primary Sponsor  
Name  Narayana multispeciality hospital 
Address  NT road Harikeri Shimoga 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr vikram  Sahyadri Narayana Multispeciality hospital  NT road Harikeri, department of anaesthesia
Shimoga
KARNATAKA 
9480664630

viky.dr40201@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Sahyadri Narayana Multispeciality hospital institutional ethical comitte  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Spinal anaesthesia   Using two techniques , premixture versus sequential drugs administration. In premixture single injection of bupivacaine and fentanyl is given. In sequential first injection is of bupivacaine followed immediately by second injection of fentanyl. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Age between 18-60 yrs.
2. ASA 1 and 2
3. Unilateral lower limb surgeries
4. Patients undergoing elective surgeries of less than 2 hours.
5. Consent to procedure
 
 
ExclusionCriteria 
Details  .Patient refusal
2. Coagulopathy
3. Infection at site of injection
4. Allergy to intrathecal drugs used.
5. Height less than 152.4cm and more than 182.8cm
6. Pregnancy.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
1. Onset of sensory blockade
2. Onset of motor blockade
3. Duration of sensory blockade
4. Duration of motor blockade
 
2 hours surgery 
 
Secondary Outcome  
Outcome  TimePoints 
1. Variation in systolic blood pressure
2. Variation in diastolic blood pressure
3. Variation in Mean arterial pressure
4. Variation in heart rate
5. Postoperative analgesia
 
2 hours surgery 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   31/03/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details    
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary    RESEARCH QUESTION     Is efficacy of intrathecal injection of bupivacaine and fentanyl as sequential administration from separate syringes better, as compared to from a single syringe?  

AIM    

To study and compare efficacy of intrathecal injection of 2.8 ml bupivacaine and 25 mcg of fentanyl in a single syringe versus sequential administration in separate syringes, in lower limb surgeries.

This is a prospective randomised double-blind study which will be performed in

a tertiary care hospital over a period of 7 months. After obtaining institutional ethical committee approval,40 patients aged 18–60years, American Society of Anaesthesiologists (ASA) grade I and II scheduled for unilateral lower limb surgery under subarachnoid block will be enrolled in this study. After written informed consent patients will be allocated into two groups of 20 patients each according to computer generated random numbers before the commencement of study. Group A patients will receive premixed 0.5% hyperbaric bupivacaine 2.8 ml(14 mg) and 0.5 ml (25 microgram) of fentanyl in a single 5.0 ml syringe.  Group B will receive 0.5% hyperbaric bupivacaine 2.8 ml (14 mg) in a 5 ml syringe followed by 0.5 ml (25 microgram) of fentanyl in a 1ml tuberculin syringe. 

Patients will undergo a thorough preanesthetic check-up a day before surgery and an informed consent will be taken.

Patients will be NPO 6 hours for solid food and 2hours for clear fluid before surgery. They will be familiarized with the concept of visual analogue scoring (VAS). Anaesthesia machine will be checked, drugs and equipment’s necessary for emergency resuscitation will be kept ready.

Intraoperative monitoring for heart rate, non-invasive blood pressure, electrocardiography, oxygen saturation (Spo2) will be connected and base line parameters will be recorded. Venous access will be established with 18-gauge cannula and Ringer lactate will be started as the maintenance fluid at rate of 10ml/kg/hour.

The drug codes sealed in envelopes numbered 1–40 will be opened by the designated anaesthesiologist of the work area just before the administration of anaesthesia and

drug prepared using sterile technique according to group allocated. The drug will then be handed over to the attending anaesthesiologist in a coded form who was unaware about the study design and the study groups. Also, the patients will be blinded to the group they belong.

Observer will not present while subarachnoid block Is administered. Twenty-six-gauge Quincke spinal needle will be used in all the cases. Patient will be placed in sitting position, back painted and draped under aseptic precautions. L4-L5 intervertebral space will be located and 26-gauge Quincke’s needle introduced. In Group A patient 5ml syringe containing 2.8ml of 0.5% bupivacaine and 0.5 ml of fentanyl will be introduced in subarachnoid space after observing free flow of CSF on aspiration. In group B patients 2.8 ml of 0.5% of bupivacaine in 5ml syringe will be introduced first in subarachnoid space after observing free flow of CSF on aspiration followed immediately by administration of 0.5ml fentanyl through a 1 ml tuberculin syringe without aspiration into the subarachnoid space. Both group patients will receive spinal injection at same rate. After the procedure patients will be placed in supine position.  Sensory block will be assessed by a sterile pin prick every 2 min till 20 min

and then after every 10 min till the highest level was achieved. Time to onset of sensory block is defined as time taken to achieve the loss of sensation at T10 dermatome. The time to onset of motor block is defined as time taken to reach Bromage score of 3. Time of sensory block regression is assessed from maximal block height attained to regression till two dermatomal level. Time of regression of motor block is assessed from Bromage score of 3 to score of 0. Vital parameters like Blood pressure, Heart rate will be assessed every 5 minutes for initial 30 min and then every15 minutes till end of surgery.  Hypotension is defined as decrease of systolic blood pressure to 80% of baseline or less and will be treated with 6 mg ephedrine given intravenously.

Bradycardia defined as HR <60 beats per minute and will be corrected using 0.6 mg of intravenous atropine sulphate. Postoperative analgesia in the form of diclofenac75mg will be given if the visual analogue score is 5 and the study will be concluded at this point. 


 
Close